mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.09 |
mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.1 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.1 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.1 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.1 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.1 |